Actively Recruiting

Age: 5Years - 55Years
All Genders
Healthy Volunteers
NCT04528446

The Impact of Glomerular Disorders on Bone Quality and Strength

Led by Columbia University · Updated on 2024-07-01

270

Participants Needed

2

Research Sites

285 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The primary objectives of this study are to: (1) determine the impact of glomerular disease on bone strength and (2) investigate the pathophysiologic underpinnings of impaired bone strength in glomerular disease.

CONDITIONS

Official Title

The Impact of Glomerular Disorders on Bone Quality and Strength

Who Can Participate

Age: 5Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant is enrolled in or eligible for the CureGN study with a diagnosis of glomerulonephropathy
  • Age between 5 and 55 years (women must be premenopausal)
  • Female participants must have a negative urine or serum pregnancy test
  • Stable doses of nutritional vitamin D or active vitamin D therapy for at least 3 months prior to enrollment (if applicable)
  • Provide informed consent or parental/guardian permission and child assent as appropriate
Not Eligible

You will not qualify if you...

  • Currently on chronic dialysis
  • History of solid organ transplantation
  • Lower extremity amputations or unable to walk
  • Active cancer requiring chemotherapy or cancer that has spread to bones
  • Diagnosed metabolic bone diseases such as Paget's disease or primary hyperparathyroidism
  • Current endocrine disorders like hyperthyroidism, untreated hypothyroidism, or Cushing's syndrome
  • Serious medical conditions including end stage liver disease, heart or lung disease, or intestinal malabsorption
  • Treatment with bisphosphonates, teriparatide, calcitonin, selective estrogen receptor modulators, estrogen, or phenytoin within the past 12 months
  • Previous bilateral fractures of the wrist or tibia
  • Pregnant or lactating females
  • Participants or guardians who may not comply with study schedules or procedures as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

2

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

M

Maria A. Aponte

CONTACT

T

Thomas L. Nickolas, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Impact of Glomerular Disorders on Bone Quality and Strength | DecenTrialz